Choline Fenofibrate

OLON is an Italian company world leader in the Active Pharmaceutical Ingredients (APIs) production, using synthetic and biological processes for Generic market as well as in Contract Development and Manufacturing (CDMO).

Always considering human safety and environmental security, OLON handles...

Relying on an experience gained over more than 50 years, OLON represent one of the most extensive know how of microbial fermentation in Europe. The Group, global leader in biomanufacturing, has two Biotechnology Centres located in Italy and is one of the first companies in Italy producing via microbial fe...

Olon relies on one of the most extensive expertise in handling highly potent pharmaceutical principles at global level, has raised the level of containment up to the actual standards and very large scale putting in place a set of primary and secondary containment designed to avoid the active substances di...

Olon SpA offers a wide range of products which includes ciclopirox. Therapeutic class: antimicotic. Contact us for more information.

CPHI WORLDWIDE,

A SIGNIFICANT EXPANSION OF APIs PIPELINE FOR OLON GROUP

Pharmaceuticals in the environment (PiE) are an important issue and the subject of increasing focus by the media, governments, NGOs and the wider public. Human and veterinary medicines bring enormous societal benefits, supporting public health and ensuring a safe food supply. One of the unintended but inevitable results of delivering life-changing medicines to patients is that pharmaceutical residues can find their way into the environment. Most are a result of patient and veterinary use and the inappropriate disposal of unused medicines. Unintended release of pharmaceuticals in manufacturing emissions represents a minor yet potentially important environmental source that is controllable and has the potential to be further minimised. This session will provide a practical introduction to the topic aimed at pharmaceutical and healthcare professionals Session in partnership with PSCI (pscinitiative.org) This presentation was originally aired as part of the CPHI Festival of Pharma.